JUSTIN FITZ: Open Payments
NPI 1386933570 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 45 payments from 13 companies in 2025. Trend: 2023 $1,037 · 2024 $666 · 2025 $963
Food & beverage: $953Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $247 |
| GENZYME CORPORATION | 6 | $198 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Incyte Corporation | 4 | $83 |
| LEO Pharma Inc. | 3 | $77 |
| Almirall LLC | 2 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| Botanix SB Inc | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Lilly USA, LLC | 1 | $31 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, OPZELURA, ADBRY, COSENTYX, Rhapsido, Klisyri.
Industry payments across FL — which companies pay providers there.
